Search
LENZ Therapeutics Inc
LENZAdd to Watchlist
4.290USD
+0.790+22.57%
Close 11-06 16:00（ET）
134.79MMarket Cap
LossP/E TTM
Today
+22.57%
5 Days
+40.66%
1 Month
+21.53%
6 Months
-57.36%
Year to Date
-73.19%
1 Year
-81.32%
Key Figures
3.570Open
4.370High
171.83KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.55%Turnover Ratio
3.500Prev. Close
3.000Low
709.55KTurnover
LossP/E Static
0.70P/B
0.00%Div Yield TTM
-46.01%ROA
32.13052wk High
0.13Volume Ratio
-49.77MNet Profit
31.42MShares
-3.6425EPS TTM
0.66Beta
-49.71%ROE
2.80052wk Low
39.14%Amplitude
86.58%Gross Margin
134.79MMarket Cap
-0.96Reward/Risk
5.13%Risk Rate
LENZ Therapeutics Inc's Score
0.07vs previous score
Forecast8.29
Financial Health6.26
Technical5.02
Valuation Dimensions7.98
Institutional Confidence10.00
Risk Assessment3.20
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
LENZ Therapeutics Inc Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Buy
LENZ Therapeutics Inc Latest Earnings Call Transcripts
LENZ Therapeutics Q3 2026 Earnings Call: VIZZ Growth and OpEx Reset
LENZ Therapeutics’ Q3 2026 earnings call covered $2.6 million in product revenue, 51% prescription growth, telehealth momentum and a major cost restructuring.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.99/-0.92
Revenue / Forecast
3.38M/4.20M
LENZ Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolLENZ
Number of employees42
Country
Ownership
| Shareholders | Proportion |
|---|---|
| RA Capital Management, LP | 13.33% |
| Fidelity Management & Research Company LLC | 11.81% |
| Alpha Wave Global, LP | 11.52% |
| Versant Ventures | 8.47% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 42.54% |
| Venture Capital | 33.60% |
| Investment Advisor/Hedge Fund | 21.57% |
| Hedge Fund | 14.43% |
Related Instruments
+4.28%
+2.13%
+0.68%
+1.38%
+0.70%
+1.59%
+1.04%
+1.46%
+2.65%
-0.54%
+0.69%
0.00%
-0.14%
+2.30%
+5.83%
+2.40%
+1.73%
+0.33%
+0.95%
+3.78%
FAQs
What is the current price of LENZ Therapeutics Inc (LENZ)?
The current price of LENZ Therapeutics Inc (LENZ) is 4.29.
What is the symbol of LENZ Therapeutics Inc?
The ticker symbol of LENZ Therapeutics Inc is LENZ.
What is the 52-week high of LENZ Therapeutics Inc?
The 52-week high of LENZ Therapeutics Inc is 32.13.
What is the 52-week low of LENZ Therapeutics Inc?
The 52-week low of LENZ Therapeutics Inc is 2.80.
What is the market capitalization of LENZ Therapeutics Inc?
The market capitalization of LENZ Therapeutics Inc is 134.79M.
Is LENZ Therapeutics Inc (LENZ) currently rated as Buy, Hold, or Sell?
According to analysts, LENZ Therapeutics Inc (LENZ) has an overall rating of Buy, with a price target of 15.00.
What is the Earnings Per Share (EPS TTM) of LENZ Therapeutics Inc (LENZ)?
The Earnings Per Share (EPS TTM) of LENZ Therapeutics Inc (LENZ) is -3.64.